SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease - PubMed (original) (raw)
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease
Jeffrey B Schwimmer et al. Gastroenterology. 2010 Apr.
Abstract
Background & aims: The appropriate alanine aminotransferase (ALT) threshold value to use for diagnosis of chronic liver disease in children is unknown. We sought to develop gender-specific, biology-based, pediatric ALT thresholds.
Methods: The Screening ALT for Elevation in Today's Youth (SAFETY) study collected observational data from acute care children's hospitals, the National Health and Nutrition Examination Survey (NHANES, 1999-2006), overweight children with and without non-alcoholic fatty liver disease (NAFLD), and children with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. The study compared the sensitivity and specificity of ALT thresholds currently used by children's hospitals vs study-derived, gender-specific, biology-based, ALT thresholds for detecting children with NAFLD, HCV, or HBV.
Results: The median upper limit of ALT at children's hospitals was 53 U/L (range, 30-90 U/L). The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free, NHANES pediatric participants were 25.8 U/L (boys) and 22.1 U/L (girls). The concordance statistics of these NHANES-derived thresholds for liver disease detection were 0.85 (95% confidence interval [CI]: 0.74-0.96) in boys and 0.91 (95% CI: 0.83-0.99) in girls for NAFLD, 0.80 (95% CI: 0.70-0.91) in boys and 0.79 (95% CI: 0.69-0.89) in girls for HBV, and 0.86 (95% CI: 0.77-0.95) in boys and 0.84 (95% CI: 0.75-0.93) in girls for HCV. Using current children's hospitals ALT thresholds, the median sensitivity for detection of NAFLD, HBV, and HCV ranged from 32% to 48%; median specificity was 92% (boys) and 96% (girls). Using NHANES-derived thresholds, the sensitivities were 72% (boys) and 82% (girls); specificities were 79% (boys) and 85% (girls).
Conclusions: The upper limit of ALT used in children's hospitals varies widely and is set too high to reliably detect chronic liver disease. Biology-based thresholds provide higher sensitivity and only slightly less specificity. Clinical guidelines for use of screening ALT and exclusion criteria for clinical trials should be modified.
Keywords: clinical trials; hepatitis; nonalcoholic fatty liver disease; obesity; patient safety.
2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
Figure 1. Inclusion and Exclusion for NHANES Reference Population
Figure 2. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Figure 2. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Figure 2. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Figure 3. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Figure 3. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Figure 3. Receiver Operating Characteristic (ROC) curves for ALT in Boys and Girls
Shown in Figure 2 for boys and Figure 3 for girls are the sensitivity and [1-specificity] of ALT in detecting Hepatitis B Viral Infection (Figure 2A, 3A), Hepatitis C Viral Infection (Figure 2B, 3B), and Nonalcoholic Fatty Liver Disease (Figure 2C, 3C). Plotted along the ROC curves are the ALT thresholds currently utilized by children’s hospitals (marked with: x) and the biologically-derived ALT threshold (marked with: o). The numbers on the ROC curves represent the median and interquartile range of ALT thresholds currently used by children’s hospitals, as well as the biologically- derived ALT threshold.
Similar articles
- Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
Kang Y, Park S, Kim S, Koh H. Kang Y, et al. BMC Pediatr. 2018 Jul 5;18(1):215. doi: 10.1186/s12887-018-1202-z. BMC Pediatr. 2018. PMID: 29976192 Free PMC article. - Updated upper limits of normal serum alanine aminotrasferase levels for screening metabolic dysfunction-associated fatty liver disease in obese children.
Lin YC, Chang PF, Ni YH. Lin YC, et al. J Formos Med Assoc. 2022 Dec;121(12):2548-2555. doi: 10.1016/j.jfma.2022.06.002. Epub 2022 Jun 21. J Formos Med Assoc. 2022. PMID: 35738972 - Alanine aminotransferase cutoffs for the pediatric fatty liver disease: Major impact of the reference population.
Aitokari L, Lahti S, Kivelä L, Riekki H, Hiltunen P, Vuorela N, Viitasalo A, Soininen S, Huhtala H, Lakka T, Kurppa K. Aitokari L, et al. J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):488-496. doi: 10.1002/jpn3.12040. Epub 2023 Dec 10. J Pediatr Gastroenterol Nutr. 2024. PMID: 38314943 - Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children.
Chang Y, Li H, Ren H, Xu H, Hu P. Chang Y, et al. Clin Chim Acta. 2019 Feb;489:61-67. doi: 10.1016/j.cca.2018.11.034. Epub 2018 Nov 29. Clin Chim Acta. 2019. PMID: 30503274 - Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.
Park HN, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Park HN, et al. Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20. Liver Int. 2012. PMID: 22260521
Cited by
- High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
Xanthakos SA, Jenkins TM, Kleiner DE, Boyce TW, Mourya R, Karns R, Brandt ML, Harmon CM, Helmrath MA, Michalsky MP, Courcoulas AP, Zeller MH, Inge TH; Teen-LABS Consortium. Xanthakos SA, et al. Gastroenterology. 2015 Sep;149(3):623-34.e8. doi: 10.1053/j.gastro.2015.05.039. Epub 2015 May 28. Gastroenterology. 2015. PMID: 26026390 Free PMC article. - Sex differences in cardiometabolic risk factors and in response to lifestyle intervention in prepubertal and pubertal subjects with obesity.
Gilardini L, Croci M, Cavaggioni L, Pasqualinotto L, Bertoli S. Gilardini L, et al. Front Pediatr. 2024 Feb 12;12:1304451. doi: 10.3389/fped.2024.1304451. eCollection 2024. Front Pediatr. 2024. PMID: 38410765 Free PMC article. - Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.
Castillo-Leon E, Morris HL, Schoen C, Bilhartz J, McKiernan P, Miloh T, Palle S, Kabbany MN, Munoz B, Mospan AR, Rudolph B, Xanthakos SA, Vos MB, Target-Nash Investigators. Castillo-Leon E, et al. Children (Basel). 2022 Mar 8;9(3):374. doi: 10.3390/children9030374. Children (Basel). 2022. PMID: 35327746 Free PMC article. - Amino Acid-Related Metabolic Signature in Obese Children and Adolescents.
Polidori N, Grasso EA, Chiarelli F, Giannini C. Polidori N, et al. Nutrients. 2022 Mar 30;14(7):1454. doi: 10.3390/nu14071454. Nutrients. 2022. PMID: 35406066 Free PMC article. Review. - Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort.
Schwarz KB, Lombardero M, Di Bisceglie AM, Murray KF, Rosenthal P, Ling SC, Cloonan YK, Rodriguez-Baez N, Schwarzenberg SJ, Hoofnagle JH, Teckman J; Hepatitis B Research Network (HBRN). Schwarz KB, et al. J Pediatr Gastroenterol Nutr. 2019 Nov;69(5):588-594. doi: 10.1097/MPG.0000000000002467. J Pediatr Gastroenterol Nutr. 2019. PMID: 31436702 Free PMC article.
References
- Jonas MM. Children with hepatitis C. Hepatology. 2002;36:S173–178. - PubMed
- Barlow S, the Expert Committee Expert Committee Recommendations on the Assessment, Prevention, and Treatment of Child and Adolescent Overweight and Obesity, Summary Report. Pediatrics. 2007;120:S164–S192. - PubMed
- Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR000827-328472/RR/NCRR NIH HHS/United States
- R21 DK071486-01/DK/NIDDK NIH HHS/United States
- P60 MD000220/MD/NIMHD NIH HHS/United States
- R21 DK071486-02/DK/NIDDK NIH HHS/United States
- P60 MD00220/MD/NIMHD NIH HHS/United States
- R21 DK071486/DK/NIDDK NIH HHS/United States
- T32 DK07202/DK/NIDDK NIH HHS/United States
- T32 DK007202/DK/NIDDK NIH HHS/United States
- T32 DK007202-30/DK/NIDDK NIH HHS/United States
- M01 RR000827-328475/RR/NCRR NIH HHS/United States
- R21 DK71486/DK/NIDDK NIH HHS/United States
- M01 RR000827-313085/RR/NCRR NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- P60 MD000220-01/MD/NIMHD NIH HHS/United States
- R24 DK080506-02/DK/NIDDK NIH HHS/United States
- R24 DK080506/DK/NIDDK NIH HHS/United States
- M01 RR000827-337033/RR/NCRR NIH HHS/United States
- M01 RR000827-337036/RR/NCRR NIH HHS/United States
- DK080506/DK/NIDDK NIH HHS/United States
- M01 RR000827-313081/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical